IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Iambic Therapeutics, Inc.
$16.34−7.47 (-31.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
1 of Iambic Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |